rediff.com
e.g. Tata motors, Reliance MF, 500570
CADILA HEALTHCARE LTD. - Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA
Download announcement < Back
18 Nov 2021
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated November 18, 2021 titled &quot;Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA&quot;.
View all announcements for CADILA HEALTHCARE LTD. Source: BSE India